CSRXP: SENATE FINANCE REPORT HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRACTICES THAT RAISE INSULIN PRICES

Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike Life-Saving Insulin Prices Without Improvements to Benefit American Patients For Immediate Release Contact: Jon Conradi

01-14-2021 Read More

BIG PHARMA WATCH: NEW STUDY FINDS DRUG COMPANIES CONTINUING TO HIKE PRICES WITHOUT IMPROVING THEIR DRUGS

Unjustified Rx Price Increases Cost American Patients & Health System Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications.

01-13-2021 Read More

CSRxP STATEMENT ON PCMA LAWSUIT CHALLENGING TRUMP ADMINISTRATION’S REBATE RULE

Misguided Policy Published in Violation of Legally Required Process for Public Input, Will Increase Premiums for Seniors, Do Nothing to Lower Drug Prices and Pad Big Pharma’s Bottom Line For

01-12-2021 Read More

BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S NEW YEAR PRICE HIKES

Second Major Round of Pandemic Price Increases Underscores Urgency for Congress to Hold Drug Companies Accountable In case you missed it, Big Pharma hiked prices on at least 629 prescription drugs

01-11-2021 Read More

HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 580 RX DRUGS TO START 2021

Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As Americans Battle Public Health Crisis For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

01-4-2021 Read More

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

Part IV: Escalating Assault on 340B Program for Providers Serving America’s Most Vulnerable Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs.

12-31-2020 Read More

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

Part III: Angling to Price-Gouge American Public on COVID-19 Treatments Taxpayers Paid to Develop Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription

12-30-2020 Read More

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

Part II: Gaming the System to Undermine Competition at the Expense of American Patients Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now

12-29-2020 Read More

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the ongoing

12-28-2020 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.